Patients with early-onset primary Sj&#xF6;gren&apos;s syndrome have distinctive clinical manifestations and circulating lymphocyte profiles

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Rheumatology (Oxford).

Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, Theander E, Kvarnström M, Forsblad-d'Elia H, Bucher SM, Norheim KB, Johnsen SJA, Hammenfors D, Skarstein K, Jonsson MV, Baecklund E, Aqrawi LA, Jensen JL, Palm Ø, Morris AP, DISSECT consortium ., the ImmunoArray consortium ., Meadows JRS, Rantapää-Dahlqvist S, Mandl T, Eriksson P, Lind L, Omdal R, Jonsson R, Lindblad-Toh K, Rönnblom L, Wahren-Herlenius M, Nordmark G

doi: 10.1093/rheumatology/keaa367.

Further Publications Rheumatology

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Rheumatology (Oxford)

Thorlacius GE, Hultin-Rosenberg L, Sandling JK, Bianchi M, Imgenberg-Kreuz J, Pucholt P, Theander E, Kvarnström M, Forsblad-d'Elia H, Bucher SM, Norheim KB, Johnsen SJA, Hammenfors D, Skarstein K, Jonsson MV, Baecklund E, Aqrawi LA, Jensen JL, Palm Ø, Morris AP, DISSECT consortium ., the ImmunoArray consortium ., Meadows JRS, Rantapää-Dahlqvist S, Mandl T, Eriksson P, Lind L, Omdal R, Jonsson R, Lindblad-Toh K, Rönnblom L, Wahren-Herlenius M, Nordmark G

doi: 10.1093/rheumatology/keaa367

EULAR ^® 2020

Sjögren’s Syndrome

Autoimmune Disease

Shared gut, but distinct oral microbiota composition in primary Sjögren's syndrome and systemic lupus erythematosus

J Autoimmun.

van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, Fu J, Wijmenga C, Weersma RK, de Leeuw K, Bootsma H, Spijkervet FKL, Vissink A, Kroese FGM

doi: 10.1016/j.jaut.2018.10.009.

Immunodeficiency

Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2

Front Immunol.

Klemann C, Camacho-Ordonez N, Yang L, Eskandarian Z, Rojas-Restrepo JL, Frede N, Bulashevska A, Heeg M, Al-Ddafari MS, Premm J, Seidl M, Ammann S, Sherkat R, Radhakrishnan N, Warnatz K, Unger S, Kobbe R, Hüfner A, Leahy TR, Ip W, Burns SO, Fliegauf M, Grimbacher B

doi: 10.3389/fimmu.2019.00297.

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study

J Am Acad Dermatol.

Mangold AR, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-Laish I, Pujol RM, Pittelkow MR, Gniadecki R

doi: 10.1016/j.jaad.2017.05.036.

Autoimmune Disease

Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial

Ann Rheum Dis

Baer AN, Gottenberg JE, St Clair EW, Sumida T, Takeuchi T, Seror R, Foulks G, Nys M, Mukherjee S, Wong R, Ray N, Bootsma H

doi: 10.1136/annrheumdis-2020-218599

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome

Arthritis Res Ther.

Hargreaves P, Daoudlarian D, Theron M, Kolb FA, Manchester Young M, Reis B, Tiaden A, Bannert B, Kyburz D, Manigold T

doi: 10.1186/s13075-019-1955-2.

Immunodeficiency

The clinical and immunological features of patients with primary antibody deficiencies

Endocr Metab Immune Disord Drug Targets.

Azizi G, Bagheri Y, Tavakol M, Askarimoghaddam F, Poorrostami K, Rafiemanesh H, Yazdani R, Kiaee F, Habibi S, Abouhamzeh K, Mohammadi H, Qorbani M, Abolhassani H, Aghamohammadi A

doi: 10.2174/

Dermatology · Immunology · Rheumatology

Patients with early-onset primary Sjögren's syndrome have distinctive clinical manifestations and circulating lymphocyte profiles

Related content

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Sjögren’s Syndrome

Shared gut, but distinct oral microbiota composition in primary Sjögren's syndrome and systemic lupus erythematosus

Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study

Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial

Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome

The clinical and immunological features of patients with primary antibody deficiencies